262
Participants
Start Date
March 12, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Liposomal Cyclosporine A 5 mg
delivered via the PARI eFlow® device, which is a new technology of nebulizing liquid drugs with a perforated vibrating membrane resulting in an aerosol with a low ballistic momentum and a high percentage of droplets in a respirable size range of 3-5 μm
Liposomal Cyclosporine A 10 mg
delivered via the PARI eFlow® device, which is a new technology of nebulizing liquid drugs with a perforated vibrating membrane resulting in an aerosol with a low ballistic momentum and a high percentage of droplets in a respirable size range of 3-5 μm
Hôpital Erasme, Brussels
Universitair Ziekenhuis Leuven, Leuven
Columbia University Medical Center, New York
University of Pittsburgh Medical Center, Pittsburgh
Temple University Hospital, Philadelphia
University of Maryland, Baltimore
Johns Hopkins University Hospital, Baltimore
Duke University, Durham
Hospital Universitario Puerta de Hierro - Unidad de Trasplante Pulmonar, Madrid
University of Florida Dept of Pulmonary Medicine, Gainesville
UK Albert B. Chandler Hospital, Lexington
OSU Wexner Medical Center, Columbus
Cleveland Clinic, Cleveland
Unidad de Trasplante Pulmonar del Hospital La Fe, Valencia
Indiana University, Indianapolis
Barnes-Jewish Hospital, St Louis
Baylor University Medical Center, Dallas
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
Houston Methodist Hospital, Houston
Banner - University Medical Center, Phoenix
David Geffen School of Medicine at UCLA, Los Angeles
Hopital Marie Lannelongue, Le Plessis-Robinson
UCSF, San Francisco
UCSF Center for Advanced Lung Disease, Stanford
Waehringer Guertel, Vienna
Copenhagen University Hospital, Copenhagen
CHU Hopital Nord, Marseille
Hopitaux Universitaires de Strasbourg, Strasbourg
Hannover Medical School, Hanover
LMU Klinikum Groshadern, Munich
Rabin Medical Center, Petah Tikva
Complexo Hospitalario de A Coruna, A Coruña
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Marques de Valdecilla, Santander
University of Manchester, Manchester
Royal Papworth Hospital NHS Foundation Trust, Cambridge
Zambon SpA
INDUSTRY